CBG

From Glioblastoma Treatments
Revision as of 10:06, 27 March 2024 by Lazy (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search
Property Information
Drug Name Cannabigerol (CBG)
FDA Approval No (CBG is a cannabinoid compound under investigation; not FDA-approved for any condition)
Used for Investigational use in cancer research for potential anti-tumor effects
Clinical Trial Phase Preclinical studies and early research
Clinical Trial Explanation Not specified
Common Side Effects Not specifically documented; cannabinoids are generally considered to have a favorable safety profile, but specific studies on CBG's side effects are limited
OS without Not specified
OS with Not applicable; research is still in preclinical stages, focusing on cellular and animal models
PFS without Not specified
PFS with Not applicable; ongoing studies aim to determine the potential impacts on tumor progression
Usefulness Rating 3
Usefulness Explanation Not specified
Toxicity Level 2
Toxicity Explanation Cannabigerol (CBG) is generally considered safe, as it's a non-psychoactive compound found in the cannabis plant. However, specific studies on CBG’s side effects are limited owing to the fact that it is in the early stages of research. Therefore, a rating of 2 is given, indicating a low level of potential toxicity. However, definitive conclusions about its toxicity can only be made after detailed human clinical trials have been conducted.

Notes: Cannabigerol (CBG), a non-psychoactive cannabinoid found in the cannabis plant, has garnered attention in preclinical studies for its potential anti-cancer properties. Research has explored CBG's effects on various cancer cell lines, including its ability to induce apoptosis, inhibit cell proliferation, and potentially target cancer stem cells. While findings are promising, indicating CBG could influence pathways involved in cancer progression, conclusive evidence from human clinical trials is awaited to fully establish its efficacy and optimal use in cancer treatment.


From Ben Williams Book: Not specified

Loading comments...